首页> 外国专利> SYNERGISTIC INIHIBITION OF TUMOR CELL PROLIFERATION INDUCED BY COMBINED TREATMENT OF METFORMIN OR METFORMIN ANALOGS AND IRON CHELATORS

SYNERGISTIC INIHIBITION OF TUMOR CELL PROLIFERATION INDUCED BY COMBINED TREATMENT OF METFORMIN OR METFORMIN ANALOGS AND IRON CHELATORS

机译：二甲双胍或二甲双胍类似物与铁螯合剂联合治疗诱导的肿瘤细胞增生协同抑制。

页面导航

摘要
著录项
相似文献

摘要

The present invention is directed to combination therapy comprising metformin or mito-metformin compounds with at least one iron chelating agent for the treatment of cancer and pharmaceutical compositions thereof.

机译：本发明涉及用于治疗癌症的包含二甲双胍或二甲双胍化合物与至少一种铁螯合剂的组合疗法。

著录项

公开/公告号US2019358247A1

专利类型
公开/公告日2019-11-28

原文格式PDF
申请/专利权人 THE MEDICAL COLLEGE OF WISCONSIN INC.;
展开▼

申请/专利号US201716472640
发明设计人 BALARAMAN KALYANARAMAN;CHRISTOPHER R. CHLTAMBAR;
展开▼

申请日2017-12-21
分类号A61K31/66;A61K31/155;A61K31/4196;A61K31/496;A61K31/197;A61K31/44;A61P35/04;
国家 US
入库时间 2022-08-21 11:19:57

相似文献

专利
外文文献
中文文献